MEDP

Medpace Holdings, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$1.0bn30-Sep-2610-Q filed 22-Oct-26
Remaining authorization$1.0bnEST30-Sep-2610-Q filed 22-Oct-26
Program expiryn/a—
Repurchased last quarter$295m31-May-2610-Q filed 23-Jul-26
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
20-Oct-26$1.0bn$1.0bnESTn/aEffective October 20, 2026, the Board approved the termination of the current share repurchase authorization and approved a new share repurchase authorization of up to $1.0 billion.10-Q filed 22-Oct-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. Apr ’26
  2. ≈$232m
    May ’26
Month endedSharesAvg price≈ ValueSource
31-May-26552,211$420.27$232m10-Q filed 23-Jul-26
30-Apr-26153,405$408.45$63m10-Q filed 23-Jul-26
Filings through 30-Sep-26· checked 18-Nov-26